AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 102 filers reported holding AMYLYX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $389 | -22.7% | 21,235 | -9.0% | 0.00% | 0.0% |
| Q2 2023 | $503 | -35.8% | 23,335 | -12.7% | 0.00% | 0.0% |
| Q1 2023 | $784 | -37.0% | 26,731 | -20.7% | 0.00% | -50.0% |
| Q4 2022 | $1,245 | -99.8% | 33,703 | +44.0% | 0.00% | +100.0% |
| Q3 2022 | $659,000 | +272.3% | 23,406 | +154.5% | 0.00% | – |
| Q2 2022 | $177,000 | +247.1% | 9,197 | +129.9% | 0.00% | – |
| Q1 2022 | $51,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,088,333 | $224,963,904 | 6.32% |
| Alpha Wave Global, LP | 821,220 | $30,344,079 | 5.54% |
| Ghost Tree Capital, LLC | 350,000 | $12,933,000 | 5.52% |
| Boxer Capital, LLC | 2,084,000 | $77,003,800 | 4.06% |
| Altium Capital Management LP | 140,000 | $5,173,000 | 2.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,693,000 | $99,506,350 | 2.06% |
| Iron Triangle Partners LP | 240,240 | $8,876,868 | 1.59% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 655,015 | $24,202,804 | 1.50% |
| EMERALD ADVISERS, LLC | 836,909 | $30,923,788 | 1.49% |
| GREAT POINT PARTNERS LLC | 190,000 | $7,020,500 | 1.38% |